Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

2400001E08Rik Inhibitors

2400001E08Rik Inhibitors belong to a specific chemical class of compounds that have been subject to scientific investigation for their potential to selectively modulate the activity of the 2400001E08Rik protein, also known as C20orf111. These inhibitors are thoughtfully designed to interact with specific regions or binding sites within the 2400001E08Rik protein, with the aim of influencing its functional activity. The study of 2400001E08Rik Inhibitors is of considerable interest due to the potential implications in understanding the biological functions and cellular processes associated with the C20orf111 protein. Through in-depth investigations, researchers seek to unravel the molecular mechanisms underlying 2400001E08Rik's involvement within cellular environments. Moreover, the exploration of these inhibitors offers valuable insights into the broader context of cellular signaling pathways and protein interactions, contributing to a deeper understanding of cellular processes that involve 2400001E08Rik.

It is essential to emphasize that the field of 2400001E08Rik Inhibitors is continuously evolving, and further research is required to fully elucidate the precise mechanisms of action and potential selectivity of these compounds for 2400001E08Rik. As with any active area of research, continued exploration of 2400001E08Rik Inhibitors holds promise in advancing our knowledge of the functions and significance of the C20orf111 protein, potentially opening new avenues for future investigations and uncovering novel biological roles. However, until more data becomes available, the full extent of the implications and potential applications of 2400001E08Rik Inhibitors remains to be elucidated.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

An EGFR (Epidermal Growth Factor Receptor) inhibitor.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

A tyrosine kinase inhibitor that targets BCR-ABL.

GSK-J4

1373423-53-0sc-507551
100 mg
$1275.00
(0)

A histone demethylase inhibitor.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

An inhibitor of the TGF-beta receptor.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A phosphoinositide 3-kinase (PI3K) inhibitor.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

An NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) inhibitor.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

An antimetabolite used in chemotherapy.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

A platinum-based chemotherapy drug that forms DNA adducts.